Alejandro Moles-Fernández

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 4

Top Topics

Breast Cancer Risk

Intellectual Disability

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Alejandro Moles-Fernández, Joanna Domènech-Vivó, Anna Tenés, Judith Balmaña, Orland Diez, Sara Gutiérrez-Enríquez
Role of Splicing Regulatory Elements and In Silico Tools Usage in the Identification of Deep Intronic Splicing Variants in Hereditary Breast/Ovarian Cancer Genes. Cancers 13 (13) (2021)
Natália Padilla, Alejandro Moles-Fernández, Casandra Riera, Gemma Montalban, Selen Özkan, Lars Ootes, Sandra Bonache, Orland Diez, Sara Gutiérrez-Enríquez, Xavier de la Cruz
BRCA1- and BRCA2-specific in silico tools for variant interpretation in the CAGI 5 ENIGMA challenge. Human mutation 40 (9) (2019)
Melissa S Cline, Giulia Babbi, Sandra Bonache, Yue Cao, Rita Casadio, Xavier de la Cruz, Orland Díez, Sara Gutiérrez-Enríquez, Panagiostis Katsonis, Carmen Lai, Olivier Lichtarge, Pier Luigi Martelli, Gilad Mishne, Alejandro Moles-Fernández, Gemma Montalban, Sean D Mooney, Robert O'Conner, Lars Ootes, Selen Özkan, Natalia Padilla, Kymberleigh A Pagel, Vikas Pejaver, Predrag Radivojac, Casandra Riera, Castrense Savojardo, Yang Shen, Yuanfei Sun, Scott Topper, Michael T Parsons, Amanda B Spurdle, David E Goldgar, null null
Assessment of blind predictions of the clinical significance of BRCA1 and BRCA2 variants. Human mutation 40 (9) (2019)
Gemma Montalban, Sandra Bonache, Alejandro Moles-Fernández, Neus Gadea, Anna Tenés, Sara Torres-Esquius, Estela Carrasco, Judith Balmaña, Orland Diez, Sara Gutiérrez-Enríquez
Incorporation of semi-quantitative analysis of splicing alterations for the clinical interpretation of variants in BRCA1 and BRCA2 genes. Human mutation 40 (12) (2019)